RE:RE:RE:time to clinic?From different sources, they are going to Nasdaq. That's why RS as they need the price over its requirement (2$)
They are changing name cause of the confusion with Stem Cell (vs cancer stem cell) and serious investors US know Trillium already.
I think they are setting up for ph 2 (easier to finance on Nasdaq) . There's a cd47 ph1 trial in Ukraine, Weissman will start his this year... mucho buzz in our feild soon ! so things could go fast in 2015...
My long calls on GILD PYCY BlUE and CELG kept my portfolio even since own spectacular fall... still hold 75K sh of SSS and will add.
Maybe will attend the meeting next week.